Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): A pilot study

Brain Research Bulletin

Volumn 86, Issue 1-2, 2011, Pages 129-133

  Ibrahim, Lobna ^a   Duncan, Wallace ^a   Luckenbaugh, David A ^a   Yuan, Peixiong ^a   Machado Vieira, Rodrigo ^a,b   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antidepressant; Depression; Neurotrophic factors; Sleep deprivation

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; VASCULOTROPIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DYSTHYMIA; FEMALE; HAMILTON SCALE; HISPANIC; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; MOOD CHANGE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; SCORING SYSTEM; SLEEP DEPRIVATION; SOCIAL PHOBIA; YOUNG MANIA RATING SCALE;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; SLEEP DEPRIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051596138     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.06.003     Document Type: Article

References (36)

1. Aitken R.C. Measurement of feelings using visual analogue scales. Proc. R. Soc. Med. 1969, 62:989-993.
2. Altar C.A., Laeng P., Jurata L.W., et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 2004, 24:2667-2677.
3. Birnbaum H.G., Kessler R.C., Kelley D., et al. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress. Anxiety 2010, 27:78-89.
4. Bocchio-Chiavetto L., Zanardini R., Bortolomasi M., et al. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur. Neuropsychopharmacol. 2006, 16:620-624.
5. Cirelli C., Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000, 885:303-321.
6. Claassen C.A., Trivedi M.H., Rush A.J., et al. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR D trial. J. Affect. Disord. 2007, 97:77-84.
7. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
8. Fernandes B., Gama C.S., Massuda R., et al. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci. Lett. 2009, 453:195-198.
9. First M.B., Spitzer R.L., Gibbon M., et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version 2002, Biometrics Research Department, New York State Psychiatric Institute, New York. Non-Patient ed.
10. Gorgulu Y., Caliyurt O. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res. Bull. 2009, 80:158-162.
11. Greene J., Banasr M., Lee B., et al. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology 2009, 34:2459-2468.
12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
13. Hoddes E., Zarcone V., Smythe H., et al. Quantification of sleepiness: a new approach. Psychophysiology 1973, 10:431-436.
14. Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005, 1037:204-208.
15. Iga J., Ueno S., Yamauchi K., et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:658-663.
16. Karege F., Perret G., Bondolfi G., et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109:143-148.
17. Lee B.H., Kim Y.K. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig. 2010, 7:231-235.
18. Machado-Vieira R., Yuan P., Brutsche N., et al. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-d-aspartate antagonist. J. Clin. Psychiatry 2009, 70:1662-1666.
19. Malberg J.E., Eisch A.J., Nestler E.J., et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
20. Manji H.K., Zarate C.A. Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics. Mol. Psychiatry 2002, 7(Suppl. 1):S1-7.
21. D.M. McNair, M. Lorr, L.F. Droppleman, EITS Manual for the Profile of Mood States, in: Educational and Industrial Testing Service, San Diego, CA, 1971.
22. Monteggia L.M., Barrot M., Powell C.M., et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10827-10832.
23. Newton S.S., Collier E.F., Hunsberger J., et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 2003, 23:10841-10851.
24. Pan W., Banks W.A., Fasold M.B., et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
25. Rush A.J., Trivedi M.H., Wisniewski S.R., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR D report. Am. J. Psychiatry 2006, 163:1905-1917.
26. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
27. Shimizu E., Hashimoto K., Okamura N., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003, 54:70-75.
28. Tadic A., Wagner S., Schlicht K.F., et al. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010.
29. Teixeira A.L., Barbosa I.G., Diniz B.S., et al. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark. Med. 2010, 4:871-887.
30. Ventriglia M., Zanardini R., Pedrini L., et al. VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:146-149.
31. Viikki M., Anttila S., Kampman O., et al. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci. Lett. 2010, 477:105-108.
32. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4647-4652.
33. Wirz-Justice A., Tobler I., Kafka M.S., et al. Sleep deprivation: effects on circadian rhythms of rat brain neurotransmitter receptors. Psychiatry Res. 1981, 5:67-76.
34. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am. J. Psychiatry 1990, 147:14-21.
35. Young R.C., Biggs J.T., Ziegler V.E., et al. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
36. Zucconi G.G., Cipriani S., Balgkouranidou I., et al. 'One night' sleep deprivation stimulates hippocampal neurogenesis. Brain Res. Bull. 2006, 69:375-381.